BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Debt History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹37 Cr | ₹28 Cr | ₹24 Cr | ₹23 Cr | ₹11 Cr |
What is the latest Total Debt ratio of BAFNA PHARMACEUTICALS ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹37 Cr |
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹24 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹11 Cr |
How is Total Debt of BAFNA PHARMACEUTICALS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹37 Cr | 32.75 | |
| Mar2025 | ₹28 Cr | 15.62 | |
| Mar2024 | ₹24 Cr | 6.39 | |
| Mar2023 | ₹23 Cr | 107.27 | |
| Mar2022 | ₹11 Cr | - | |
Compare Total Debt of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹764.3 Cr | 6.4% | 30.5% | 172.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 6.4% |
30.5% |
172.5% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses